Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?

Raquel Guillamat-Prats (Barcelona, Spain), Raquel Guillamat-Prats, Marta Camprubí-Rimblas, Ferranda Puig, Raquel Herrero, Anna Serrano-Mollar, Jessica Tijero, Maria Nieves Gómez, Lluís Blanch, Antonio Artigas

Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Session: Novel insights into alveolar and bronchial epithelial cell injury and repair
Session type: Thematic Poster
Number: 945

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Raquel Guillamat-Prats (Barcelona, Spain), Raquel Guillamat-Prats, Marta Camprubí-Rimblas, Ferranda Puig, Raquel Herrero, Anna Serrano-Mollar, Jessica Tijero, Maria Nieves Gómez, Lluís Blanch, Antonio Artigas. Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells?. Eur Respir J 2016; 48: Suppl. 60, 945

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-?B pathway
Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage
Year: 2015


Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Heparin effect in pulmonary cell populations in an in-vitro model of acute lung injury
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016


Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


LATE-BREAKING ABSTRACT: Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016



LATE-BREAKING ABSTRACT: Trasplantation of alveolar type II cells in experimental Acute Lung Injury
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014

Essential oils reduced lung inflammation in a model of acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014

Expression of water and ion channels proteins in acute respiratory distress syndrome from different etiologies
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014

Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015

Effect of alveolar type II cells in acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Characterization of ceramide generation kinetics in a lung injury model induced by lipopolysaccharide
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015

New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Human mesenchymal stem cells (MSC) modulate alveolar macrophage polarization in vivo and in vitro.
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014

Mesenchymal stem cell-conditioned medium induces neutrophils apoptosis via inhibition of NF-kB pathway and increases endogenous pulmonary stem cells in endotoxin-induced acute lung injury
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015

Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
Source: International Congress 2014 – ILDs 6
Year: 2014

The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Markers of poor outcome in patients with acute hypoxemic respiratory failure
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014